ORIC
Oric Pharmaceuticals Inc
NASDAQ: ORIC · HEALTHCARE · BIOTECHNOLOGY
$9.88
+4.66% today
Updated 2026-04-30
Market cap
$977.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.47
Dividend yield
—
52W range
$5 – $15
Volume
2.1M
Oric Pharmaceuticals Inc (ORIC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $30.02M | $46.73M | $94.09M | $299.00M | $298.64M | $250.36M | $254.69M | $274.14M |
| Cash & equivalents | $25.82M | $42.64M | $89.16M | $78.45M | $226.01M | $66.84M | $23.38M | $59.41M |
| Current assets | $26.61M | $43.72M | $90.00M | $296.70M | $240.52M | $210.46M | $212.60M | $262.25M |
| Total liabilities | $4.30M | $111.16M | $6.12M | $9.22M | $25.67M | $28.01M | $30.60M | $31.02M |
| Current liabilities | $2.61M | $2.60M | $5.35M | $9.00M | $15.15M | $15.39M | $20.46M | $24.85M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | $25.73M | $-64.43M | $87.97M | $289.78M | $272.98M | $222.35M | $224.09M | $243.12M |
| Retained earnings | $-44.44M | $-65.81M | $-92.69M | $-166.39M | $-245.11M | $-334.23M | $-434.93M | $-562.77M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |